Gapping down
In reaction to disappointing earnings/guidance:
In reaction to disappointing earnings/guidance:
- OREX -14.3%, (guidance)
- NHTC -10.1%, (guidance)
Other news:
- TGTX -16.4% (provides update on FDA meeting for genuine phase 3 trial, the FDA confirmed that accelerated approval based on Overall Response Rate would be a review issue; completes full enrollment in the UNITY-CLL Phase 3 trial)
- LPCN -2.3% (files for $150 mln mixed securities shelf offering)
- BBVA -1.5% (continued volatility in Spanish banks)
- SAN -0.6% (continued volatility in Spanish banks)
Analyst comments:
- MGA -2.8% (downgraded to Sell from Neutral at Goldman)
- ADBE -2.2% (downgraded to Hold from Buy at Deutsche Bank)
- LQ -1.6% (downgraded to Equal-Weight from Overweight at Morgan Stanley)
- OMC -1.5% (downgraded to Underweight from Equal-Weight at Morgan Stanley)
- CSX -1.1% (downgraded to Market Perform from Outperform at Wells Fargo )
- MIDD -1% (downgraded to Sector Weight from Overweight at KeyBanc Capital Mkts)
- BMY -0.9% (downgraded to Hold from Buy at Jefferies)
- C -0.5% (downgraded to Sell from Hold at Societe Generale)